Comparison of Quadro Iliac vs Erector Spinae Plane Block on Postoperative Pain and Opioid Use in … (NCT06656507) | Clinical Trial Compass
CompletedNot Applicable
Comparison of Quadro Iliac vs Erector Spinae Plane Block on Postoperative Pain and Opioid Use in Lumbar Discectomies
Turkey (Türkiye)60 participantsStarted 2024-11-01
Plain-language summary
This multicenter, randomized, controlled study aims to compare the analgesic efficacy of Quadro Iliac Plane Block (QIPB) and Erector Spinae Plane (ESP) Block in lumbar vertebra surgeries. The study will evaluate postoperative pain management, opioid consumption, side effects, hospital stay duration, and patient satisfaction. Patients scheduled for single-level lumbar disk herniation surgery will be randomized to receive either the QIPB or ESP block before awakening from anesthesia. Pain scores will be measured at multiple postoperative time points, and opioid consumption will be monitored using patient-controlled analgesia (PCA). The study seeks to identify the most effective and safe method for postoperative pain management in lumbar surgeries.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients aged 18 to 65 years.
* ASA physical status classification I-III.
* Patients scheduled for single-level lumbar disk herniation surgery.
* No history of bleeding diathesis.
* No history of anticoagulant use.
* No known allergies to the medications used in the study (e.g., bupivacaine).
* No history of neuropathic diseases.
* Patients who have provided informed consent to participate in the study.
Exclusion Criteria:
* Patients younger than 18 or older than 65 years.
* ASA physical status classification IV or higher.
* Patients with a history of coagulopathy or bleeding disorders.
* Patients with a history of chronic opioid use or substance abuse.
* Patients with allergies to local anesthetics (e.g., bupivacaine).
* Patients with significant neuropathic conditions or central nervous system disorders.
* Patients with any contraindication to regional anesthesia.
* Pregnant or breastfeeding women.
* Patients unable to provide informed consent.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
NRS Score
Timeframe: 24 hours
Trial details
NCT IDNCT06656507
SponsorKanuni Sultan Suleyman Training and Research Hospital